EIF1B Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population targeting the EIF1B gene. This pool of HEK293T cells carries diverse gene disruptions, enabling loss-of-function studies without clonal selection. The polyclonal format maintains heterogeneity while providing robust knockout effects for bulk assays, making it ideal for exploring translational biology in a high-transfectability host.
The HEK293T host line, derived from human embryonic kidney, is an adherent epithelial line transformed with SV40 large T antigen and adenovirus E1A. These features confer exceptional transfection efficiency and support episomal plasmid replication, positioning HEK293T as a standard for transient protein expression, viral packaging, and reporter assays. Their rapid proliferation and consistent performance ensure reliable experimental output, while the EIF1B knockout introduces a specific perturbation to translation initiation within this tractable system.
EIF1B is a core translation initiation factor that assembles into the 43S preinitiation complex along with eIF1, eIF2, eIF3, eIF5, and the 40S ribosomal subunit. It facilitates ribosomal scanning and ensures accurate start codon recognition, thereby controlling the fidelity of protein synthesis. EIF1B function is regulated by mTORC1 and eIF2?? kinases (PERK, GCN2, PKR), linking it to nutrient and stress signaling. Downstream, EIF1B impacts the translation of cap-dependent mRNAs, particularly those with structured 5?? UTRs, and works in concert with eIF4E, eIF4G, eIF4A, and 4E-BP1. Thus, EIF1B sits at a critical node connecting growth signals to translational output.
In HEK293T cells, EIF1B knockout disrupts 43S complex function, leading to aberrant start site selection and diminished translational fidelity. This triggers proteostatic stress and often activates the integrated stress response, marked by elevated eIF2?? phosphorylation. The high basal translation rate of HEK293T cells amplifies the phenotypic consequences, making this an attractive model to study the interplay between translation initiation and cellular signaling. It enables researchers to dissect how EIF1B loss reprograms protein synthesis and affects cell growth under normal and stress conditions.
Applications include polysome profiling and ribosome profiling to analyze translation dynamics, puromycin incorporation assays for bulk protein synthesis measurement, and dual-luciferase reporters to assess cap-dependent versus IRES-mediated initiation. The knockout cells are also suited for phospho-eIF2?? immunoblotting to monitor stress pathway activation and for screens of translation inhibitors. Additionally, they can be employed to evaluate viral RNA translation mechanisms and investigate EIF1B??s role in cancer and neurodevelopment. For technical inquiries, contact Ascent Research.
